Dolby Laboratories, Inc.
US ˙ NYSE ˙ US25659T1079

SecurityDLB / Dolby Laboratories, Inc.
InstitutionOak Thistle LLC
Latest Disclosed Ownership40,644 shares
Latest Disclosed Value $ 2,441,079
Oak Thistle LLC reports 61.39% increase in ownership of DLB / Dolby Laboratories, Inc.

On April 10, 2026 - Oak Thistle LLC filed a 13F-HR form disclosing ownership of 40,644 shares of Dolby Laboratories, Inc. (US:DLB) valued at $2,441,079 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 25,184 shares of Dolby Laboratories, Inc.. This represents a change in shares of 61.39% during the quarter. The current value of the position is $2,185,834 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 40,644 15,460 61.39 2,441 50.96 0.2370
2026-01-21 2025-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 25,184 25,184 1,617 0.2247
2025-10-07 2025-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 0 -25,243 -100.00 0 -100.00
2025-08-08 2025-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 25,243 8,364 49.55 1,875 38.30 0.2761
2025-05-06 2025-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 16,879 16,879 1,356 0.2729
2024-08-06 2024-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 0 -4,568 -100.00 0 -100.00
2024-04-18 2024-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 4,568 -8,464 -64.95 383 -65.98 0.3434
2024-01-22 2023-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 13,032 334 2.63 1,123 11.63 0.3227
2023-10-18 2023-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 12,698 3,032 31.37 1,006 24.50 0.2973
2023-07-26 2023-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 9,666 9,666 809 0.4269
2023-02-06 2022-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 0 -3,282 -100.00 0 -100.00
2022-10-17 2022-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 3,282 3,282 214 0.7715
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.